Item 8.01 Other Events
On June 10, 2009, Medicis Pharmaceutical Corporation ("Medicis"), Medicis Pediatrics, Inc. ("Medicis Pediatrics," formerly known as Ascent Pediatrics, Inc.), a wholly-owned subsidiary of Medicis, and BioMarin Pharmaceutical Inc. ("BioMarin") entered into an amendment (the "Amendment") to the Securities Purchase Agreement (the "Securities Purchase Agreement"), dated as of May 18, 2004 and amended on January 12, 2005, by and among Medicis, Medicis Pediatrics, BioMarin and BioMarin Pediatrics Inc., a wholly-owned subsidiary of BioMarin that previously merged into BioMarin. The Amendment was effected to accelerate the closing of BioMarin's option under the Securities Purchase Agreement to purchase from Medicis all of the issued and outstanding capital stock of Medicis Pediatrics (the "Option"), which was previously expected to close in August 2009. In accordance with the Amendment, the parties consummated the closing of the Option on June 10, 2009 (the "Option Closing"). The aggregate cash consideration paid to Medicis in conjunction with the Option Closing was approximately $70.6 million and the purchase was completed substantially in accordance with the previously disclosed terms of the Securities Purchase Agreement. The name of Medicis Pediatrics was changed to BioMarin Pediatrics II, Inc. in conjunction with the Option Closing.

---